纳斯达克(NDAQ)
搜索文档
Got $10,000? This Unique Nasdaq ETF Could Turn It Into About $1,000 of Income Each Year.
The Motley Fool· 2024-11-23 17:27
The Nasdaq-100 Index is all about growth stocks -- it holds the top nonfinancial stocks listed on the Nasdaq stock exchange. That growth focus has enabled the index to deliver superior investment returns: It has more than doubled the return of the S&P 500 over the last 15 years.If there's one drawback to the Nasdaq-100, it's that it doesn't produce much income (the index's dividend yield is currently 0.8%). However, there is a way to have your proverbial cake and eat it too.The JPMorgan Nasdaq Equity Premiu ...
Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
GlobeNewswire News Room· 2024-11-23 07:23
公司反向股票分割相关情况 - 反向股票分割基本信息 11月27日午夜起实施1 - 200的反向股票分割以满足纳斯达克每股1美元最低出价要求[1] - 关键细节 每200股已发行和流通普通股将自动合并为1股股东无需操作享有零碎股份股东将获得整股新CUSIP编号交易代码仍为ELAB[2] - 股权调整 已发行股票奖励期权和股权激励计划已按比例调整以反映新的股权结构[3] 反向股票分割目的 - 确保符合纳斯达克上市要求维持上市地位提升公司知名度增强投资者信心为未来增长奠定基础[3] 对股东影响 - 无需立即行动通过经纪人持股或街名持股股东持股将自动更新持有实物股票证书股东可按需通过VStock Transfer LLC交换会提供详细说明[4] - 不影响股东权益总值仅减少流通股数量并按比例调整股价[5] 对普通股影响及展望 - 反向股票分割后将有大约307万股已发行和流通普通股[6] - 反向股票分割是保持纳斯达克上市的必要措施公司对未来持乐观态度并致力于执行增长战略[6] 公司概况 - 专注于医疗美容和生物制药药物开发重点在皮肤美容以及与肥胖和代谢健康相关的治疗旗下有三个全资子公司[7]
Stran & Company Receives Additional Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
GlobeNewswire News Room· 2024-11-23 05:30
公司未按时提交财报相关 - Stran公司收到纳斯达克上市资格部门通知 因其未能及时提交截至2024年9月30日的季度报告(10 - Q表)不符合纳斯达克上市规则中的及时提交标准 [1] - 纳斯达克之前给予公司例外期限至2024年12月16日来提交2024年3月31日和6月30日的逾期季度报告 额外的例外期限最多为自首次逾期提交到期日起180个日历日即到2024年12月16日 公司需在2024年12月6日前向纳斯达克提交恢复合规计划的更新 [2] - 公司打算提交所需的计划更新并采取必要步骤尽快恢复遵守纳斯达克上市规则 但无法保证能够恢复或维持合规 [3] 公司股票及认股权证上市情况 - 通知信对公司普通股或认股权证在纳斯达克资本市场的上市没有直接影响 [4] 公司概况 - Stran在促销产品行业已发展成为领导者 有29年历史 专注于复杂营销计划 帮助认识促销产品、品牌商品和忠诚度激励计划的价值以提高知名度、建立品牌和影响销售 是许多财富500强公司的促销计划管理者 提供世界级客户服务并利用前沿技术 使命是与客户建立长期关系以建立持久品牌忠诚度 更多信息可在www.stran.com获取 [5]
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
GlobeNewswire News Room· 2024-11-23 05:01
GEELONG, Australia, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that the Company has received a notification letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company ...
Thumzup to Ring the Nasdaq Opening Bell on November 22, 2024
GlobeNewswire News Room· 2024-11-22 05:05
Thumzup CEO Robert Steele to be featured on Nasdaq’s Behind the Bell series for same-day interviewCompany’s model compares to that of Uber’s democratization of ride-sharingEmpowering gig economy workers with disruptive technology to get paid to post on social media Los Angeles, CA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions that allows businesses and brands to pay cust ...
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Benzinga· 2024-11-22 03:39
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 500 points on Thursday.The Dow traded up 1.24% to 43,945.57 while the NASDAQ rose 0.09% to 18,982.36. The S&P 500 also rose, gaining, 0.62% to 5,953.83.Check This Out: Jim Cramer Likes Devon Energy, But Calls Another Stock ‘Far Superior‘Leading and Lagging SectorsEnergy shares rose by 1.6% on Thursday.In trading on Thursday, communication services shares fell by 2.3%.Top HeadlineShares of Baidu, Inc BIDU fell ...
Iterum Therapeutics Regains Full Nasdaq Compliance
GlobeNewswire News Room· 2024-11-21 21:30
DUBLIN and CHICAGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced receipt of written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC informing the Company that its deficiency under Listing Rule 5550(b) has been cured and that the Company is in complia ...
Nasdaq, Wall Street to drop as Nvidia slides after earnings
Proactiveinvestors NA· 2024-11-21 18:56
About this content About Josh Lamb After graduating from the University of Kent in the summer of 2022 with a degree in History, Josh joined Proactive later that year as a journalist in the UK editorial team. Josh has reported on a range of areas whilst at Proactive, including energy companies during a time of global crisis, aviation and airlines as the sector recovers from the pandemic, as well as covering economic, social and governance issues. Read more About the publisher Proactive financial news and ...
Meet the Newest AI Stock in the Nasdaq-100. It Soared 2,140% in 2 Years and Is Still a Buy, According to a Wall Street Analyst.
The Motley Fool· 2024-11-21 17:35
The Nasdaq-100 tracks the 100 largest non-financial companies on the Nasdaq Stock Market. On Nov. 18, mobile advertising company AppLovin (APP 1.25%) joined the index, replacing discount store Dollar Tree.AppLovin has been one of the fastest-growing stocks on the market. Its share price surged 2,140% during the last two years, more than doubling Nvidia's return during that period. Yet among the 29 analysts that follow the company, 79% still rate the stock a buy.Moreover, James Callahan at Piper Sandler rece ...
Nasdaq Traders Brace for Volatility as Nvidia's Q4 Guidance Signals Supply Constraints
FX Empire· 2024-11-21 06:49
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...